Trading Ideas

Traders Circulate PennyStocks.com Report Mentioning NuZee, Spectrum Pharmaceuticals, Invacare, Bluejay Diagnostics, Bit Brother

https://pennystocks.com/featured/2021/12/09/best-penny-stocks-to-buy-now-10-short-squeeze-stocks-to-watch/

byBenzinga Newsdesk

December 9, 2021

1 minute read

Best Penny Stocks To Buy Now? 10 Short Squeeze Stocks To Watch

Cryptocurrency Stellar Decreases More Than 8% Within 24 hours

By Benzinga Insights

Today, 6:29 AM

Stellar's (CRYPTO: XLM) price has decreased 8.58% over the past 24 hours to $0.28, continuing its downward trend over the past week of -12.0%, moving from $0.32 to its current price.

$XLM

Impossible Foods Is Said In Fundraising Talks At $7B Valuation; Beyond Meat Shares Move Higher On Volume

By Benzinga Newsdesk

Today, 6:29 AM

-Bloomberg https://www.bloomberg.com/news/articles/2021-10-28/impossible-foods-is-said-to-eye-7-billion-value-in-fundraising?sref=vdKurlBI

BYND

Xenon Pharmaceuticals Raises $300M Via Equity

By Vandana Singh

Today, 6:29 AM

Xenon Pharmaceuticals Inc (NASDAQ:XENE) priced its underwritten public offering of 8.5 million shares and pre-funded warrants to purchase up to 1.7…

XENE

After FDA Rejection, EMA Approves FibroGen-Astellas’ Roxadustat

By Vandana Singh

Today, 6:29 AM

The European Commission (EC) has approved FibroGen Inc (NASDAQ:FGEN) and Astellas Pharma’s (OTC:ALPMF) Evrenzo (roxadustat) for anemia caused by chronic kidney disease (CKD),…

AKBA

Traders Circulate PennyStocks.com Report Mentioning NuZee, Spectrum Pharmaceuticals, Invacare, Bluejay Diagnostics, Bit Brother

Related Posts

Cryptocurrency Stellar Decreases More Than 8% Within 24 hours

Impossible Foods Is Said In Fundraising Talks At $7B Valuation; Beyond Meat Shares Move Higher On Volume

Xenon Pharmaceuticals Raises $300M Via Equity

After FDA Rejection, EMA Approves FibroGen-Astellas’ Roxadustat